Substrain of SARS-CoV-2 variant in UK may resist antibody neutralization
Substrain of SARS-CoV-2 variant in UK may resist antibody neutralization Researchers at the Polish Academy of Sciences in Warsaw have identified a substrain of the recently emerged B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may confer resistance to antibody neutralization. The SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that has now claimed the lives of more than 2.35 million people. The substrain of the B.1.1.7 variant of concern (VOC) contains mutations that have previously been shown to compromise ...